
Serum uric acid is an independent risk factor of worse mid- and long-term outcomes in patients with non-ST-segment elevation acute coronary syndromes
Author(s) -
Maciej Dyrbuś,
Piotr Desperak,
Marta Pawełek,
Mateusz Możdżeń,
Mariusz Gąsior,
Michał Hawranek
Publication year - 2021
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2021.0156
Subject(s) - medicine , acute coronary syndrome , myocardial infarction , cardiology , quartile , coronary artery disease , stroke (engine) , st elevation , incidence (geometry) , population , revascularization , prospective cohort study , confidence interval , mechanical engineering , physics , environmental health , optics , engineering
The data on the association between serum uric acid (sUA) concentration and outcomes in patients with an ACS are inconsistent and do not focus on patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS). The aim of this study was to analyze an association of sUA concentration on admission and outcomes in those patients.